Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human, Rat|
|Published species reactivity||Rat|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Recombinant fragment corresponding to a region within amino acids 1 and 166 of Human GPD1|
|Purification||Antigen affinity chromatography|
|Storage buffer||0.1M tris glycine, pH 7, with 20% glycerol|
|Storage Conditions||-20° C, Avoid Freeze/Thaw Cycles|
|Tested Applications||Dilution *|
|Immunohistochemistry (Paraffin) (IHC (P))||1:100-1:1000|
|Western Blot (WB)||1:500-1:3000|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
|Western Blot (WB)||See 1 publications below|
PA5-31051 targets GPD1 in IF, IHC (P), and WB applications and shows reactivity with Human and Rat samples.
The PA5-31051 immunogen is recombinant fragment corresponding to a region within amino acids 1 and 166 of Human GPD1.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Hepatic AQP9 expression in male rats is reduced in response to PPARα agonist treatment.
PA5-31051 was used in western blot to examine the effect of PPARalpha agonist administration on hepatic AQP9 expression and enzymes involved in glycerol metabolism
|Lebeck J,Cheema MU,Skowronski MT,Nielsen S,Praetorius J||American journal of physiology. Gastrointestinal and liver physiology (308:G198)||2015|
cytoplasmic; glycerol 3-phosphate dehydrogenase; glycerol-3-phosphate dehydrogenase; glycerol-3-phosphate dehydrogenase 1 (soluble); Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic; glycerol-3-phosphate dehydrogenase [NAD+]; glycerol-3-phosphate dehydrogenase [NAD+], cytoplasmic; glycerophosphate dehydrogenase; GPD-C; GPDH-C; soluble
GPD-C; GPD1; Gpd3; GPDH; GPDH-C; HTGTI